author-photo

Scott Brian Saxman

Eli Lilly and Company

3

Papers

103

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Ethical Considerations for Outcome‐Adaptive Trial Designs: A Clinical Researcher's Perspective

2015 Bioethics
- Scott Brian Saxman
Show All
- Source
- Cite
- Save
Citations (31)
Commentary on Hey and Kimmelman

2015 Clinical Trials
- Scott Brian Saxman
Show All
- Source
- Cite
- Save
Citations (13)
Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial

2013 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (59)